This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n15https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
n4https://benthamscience.com/journals/current-cancer-drug-targets/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
dbpedia-frhttp://fr.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbpedia-nlhttp://nl.dbpedia.org/resource/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Current_Cancer_Drug_Targets
rdf:type
dbo:PeriodicalLiterature yago:Whole100003553 dbo:Work dbo:WrittenWork yago:Work104599396 wikidata:Q1092563 yago:WikicatOncologyJournals yago:WikicatPublicationsEstablishedIn2001 yago:Creation103129123 yago:Publication106589574 yago:WikicatBenthamSciencePublishersAcademicJournals yago:Periodical106593296 yago:Product104007894 yago:WikicatEnglish-languageJournals wikidata:Q234460 yago:PhysicalEntity100001930 wikidata:Q386724 schema:CreativeWork owl:Thing dbo:AcademicJournal yago:Object100002684 yago:Artifact100021939
rdfs:label
Current Cancer Drug Targets Current Cancer Drug Targets Current Cancer Drug Targets Current Cancer Drug Targets
rdfs:comment
Current Cancer Drug Targets, abgekürzt Curr. Cancer Drug Targets, ist eine wissenschaftliche Fachzeitschrift, die vom Bentham Science-Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit neun Ausgaben im Jahr. Es werden Arbeiten veröffentlicht, die sich mit Zielstrukturen für Arzneimittel zur onkologischen Therapie beschäftigen. Der Impact Factor lag im Jahr 2015 bei 3,707. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Onkologie an 68. Stelle von 213 Zeitschriften geführt. Current Cancer Drug Targets est une revue médicale de cancérologie qui ambitionne de couvrir les développements récents et remarquables de la chimie médicale, la pharmacologie, la biologie moléculaire, la génomique, et la biochimie des cibles potentielles de drogues moléculaires dans le cancer. Il peut s'agir, par exemple, de protéines spécifiques de la maladie, de récepteurs, d'enzymes, de gènes… Chaque numéro du journal contient une série de revues approfondies, et au plus près de l'actualité, écrites par des personnalités de référence en la matière. Current Cancer Drug Targets is een internationaal, aan collegiale toetsing onderworpen wetenschappelijk tijdschrift op het gebied van de oncologie. De naam wordt in literatuurverwijzingen meestal afgekort tot Curr. Cancer Drug Targets. Het wordt uitgegeven door en verschijnt 9 keer per jaar. Het eerste nummer verscheen in 2001. Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
foaf:homepage
n4:
dcterms:subject
dbc:Bentham_Science_Publishers_academic_journals dbc:Publications_established_in_2001 dbc:Oncology_journals dbc:11_times_per_year_journals dbc:English-language_journals
dbo:wikiPageID
32633223
dbo:wikiPageRevisionID
1028495800
dbo:wikiPageWikiLink
dbr:Scopus dbr:Molecular_biology dbr:EMBiology dbr:Medicinal_chemistry dbr:Bentham_Science_Publishers dbr:Biochemistry dbr:EMBASE dbr:Genomics dbc:Bentham_Science_Publishers_academic_journals dbc:Publications_established_in_2001 dbr:Science_Citation_Index dbr:University_of_Houston dbc:Oncology_journals dbr:Editor-in-chief dbr:MEDLINE dbr:Chemical_Abstracts_Service dbr:Cancer dbr:Medical_journal dbc:11_times_per_year_journals dbr:Peer-reviewed dbr:Oncology dbr:Pharmacology dbr:Impact_factor dbr:Journal_Citation_Reports dbc:English-language_journals
dbo:wikiPageExternalLink
n4:
owl:sameAs
freebase:m.0h3rpm8 n15:34vQF yago-res:Current_Cancer_Drug_Targets dbpedia-fr:Current_Cancer_Drug_Targets dbpedia-nl:Current_Cancer_Drug_Targets dbpedia-de:Current_Cancer_Drug_Targets wikidata:Q332547
dbp:wikiPageUsesTemplate
dbt:Reflist dbt:Infobox_journal
dbp:impact
2.912
dbp:abbreviation
Curr. Cancer Drug Targets
dbp:discipline
dbr:Oncology
dbp:editor
Ruiwen Zhang
dbp:frequency
11
dbp:history
2001
dbp:issn
1568
dbp:link
n4:
dbp:oclc
48132748
dbp:publisher
dbr:Bentham_Science_Publishers
dbp:website
n4:
dbo:abstract
Current Cancer Drug Targets, abgekürzt Curr. Cancer Drug Targets, ist eine wissenschaftliche Fachzeitschrift, die vom Bentham Science-Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit neun Ausgaben im Jahr. Es werden Arbeiten veröffentlicht, die sich mit Zielstrukturen für Arzneimittel zur onkologischen Therapie beschäftigen. Der Impact Factor lag im Jahr 2015 bei 3,707. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Onkologie an 68. Stelle von 213 Zeitschriften geführt. Current Cancer Drug Targets is een internationaal, aan collegiale toetsing onderworpen wetenschappelijk tijdschrift op het gebied van de oncologie. De naam wordt in literatuurverwijzingen meestal afgekort tot Curr. Cancer Drug Targets. Het wordt uitgegeven door en verschijnt 9 keer per jaar. Het eerste nummer verscheen in 2001. Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters"). Current Cancer Drug Targets est une revue médicale de cancérologie qui ambitionne de couvrir les développements récents et remarquables de la chimie médicale, la pharmacologie, la biologie moléculaire, la génomique, et la biochimie des cibles potentielles de drogues moléculaires dans le cancer. Il peut s'agir, par exemple, de protéines spécifiques de la maladie, de récepteurs, d'enzymes, de gènes… Chaque numéro du journal contient une série de revues approfondies, et au plus près de l'actualité, écrites par des personnalités de référence en la matière.
dbp:coden
CCDTB9
dbp:eissn
1873
dbp:impactYear
2019
dbp:link1Name
Online access
dbp:link2Name
Online archive
dbo:impactFactor
2.912
dbo:impactFactorAsOf
2019-01-01
gold:hypernym
dbr:Journal
prov:wasDerivedFrom
wikipedia-en:Current_Cancer_Drug_Targets?oldid=1028495800&ns=0
dbo:wikiPageLength
2798
dbo:abbreviation
Curr. Cancer Drug Targets
dbo:firstPublicationYear
2001-01-01
dbo:frequencyOfPublication
11/year
dbo:issn
1568-0096 1873-5576
dbo:oclc
48132748
dbo:coden
CCDTB9
dbo:academicDiscipline
dbr:Oncology
dbo:publisher
dbr:Bentham_Science_Publishers
foaf:isPrimaryTopicOf
wikipedia-en:Current_Cancer_Drug_Targets
Subject Item
dbr:Cyclin_E1
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:CDC23
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:RUNX1
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:Curr._Cancer_Drug_Targets
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
dbo:wikiPageRedirects
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:Curr_Cancer_Drug_Targets
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
dbo:wikiPageRedirects
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:Non-homologous_end-joining_factor_1
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:Survivin
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
Subject Item
dbr:Mucin_short_variant_S1
dbo:wikiPageWikiLink
dbr:Current_Cancer_Drug_Targets
Subject Item
wikipedia-en:Current_Cancer_Drug_Targets
foaf:primaryTopic
dbr:Current_Cancer_Drug_Targets